ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : BACTERIAL GENETICS
Field of Research : Medical Bacteriology
Clear All
Filter by Field of Research
Medical Bacteriology (118)
Microbial Genetics (2)
Bacteriology (1)
Infectious Diseases (1)
Medical Microbiology (1)
Microbiology (1)
Filter by Socio-Economic Objective
Environmental health (1)
Expanding Knowledge in the Biological Sciences (1)
Expanding Knowledge in the Medical and Health Sciences (1)
Infectious diseases (1)
Preventive Medicine (1)
Respiratory system and diseases (incl. asthma) (1)
Filter by Funding Provider
National Health and Medical Research Council (116)
Australian Research Council (2)
Filter by Status
Closed (118)
Filter by Scheme
Project Grants (65)
NHMRC Project Grants (25)
Early Career Fellowships (9)
Career Development Fellowships (4)
Research Fellowships (4)
NHMRC Postgraduate Scholarships (3)
Practitioner Fellowships (3)
ARC Future Fellowships (2)
Program Grants (2)
Postgraduate Scholarships (1)
Filter by Country
Australia (13)
Filter by Australian State/Territory
QLD (6)
VIC (6)
NSW (1)
NT (1)
  • Researchers (6)
  • Funded Activities (118)
  • Organisations (17)
  • Funded Activity

    Expression And Secretion Of Large Clostridial Toxins From The Pathogenic Clostridia.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $332,258.00
    Summary
    The large clostridial toxins are an important family of bacterial virulence factors that includes toxins from many disease-causing clostridial species. Despite their impact on public health, pathogenesis of disease caused by these bacteria is poorly understood. We will analyse how these bacteria regulate the production and secretion of the large toxins, which will give us a better understanding of the mechanisms of disease causation as well as identifying novel common therapeutic targets.
    More information
    Funded Activity

    The Role Of Clostridium Difficile Spore Surface Structures In Initiating Gastrointestinal Infection And Disease.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $467,556.00
    Summary
    Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with more virulent isolates emerging overseas since 2000. These strains were detected in Australia in 2010 and are now spreading throughout our hospitals. This project will increase our understanding of how these strains are transmitted to susceptible hosts and why they are so harmful, which is critical for the development of better strategies for preventing and treating these infection .... Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with more virulent isolates emerging overseas since 2000. These strains were detected in Australia in 2010 and are now spreading throughout our hospitals. This project will increase our understanding of how these strains are transmitted to susceptible hosts and why they are so harmful, which is critical for the development of better strategies for preventing and treating these infections.
    Read more Read less
    More information
    Funded Activity

    The Role Of Clostridium Difficile Virulence Factors In Mediating The Host-pathogen Interactions That Lead To Gastrointestinal Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $444,351.00
    Summary
    Hospital-acquired infections with the bacterium Clostridium difficile are a major global public health concern with more virulent isolates emerging overseas since 2000. These strains were detected in Australia in 2010 and are now spreading throughout our hospitals. This project will increase our understanding of how these strains cause disease and why they are more harmful, which is critical for the development of improved strategies for preventing and treating these infections.
    More information
    Funded Activity

    Evolution And Pathogenicity Of NDM-1 Positive Escherichia Coli

    Funder
    National Health and Medical Research Council
    Funding Amount
    $643,275.00
    Summary
    Antibiotic resistance (AR), as highlighted by the WHO, is the most pressing medical need of the 21C – some infections are now untreatable. Our research will focus on the new "superbug" NDM-1 positive E. coli. We will correlate AR and pathogenicity and explore the evolution of these "superbugs" using state-of-the-art sequencing. This research will benefit Australian medicine by predicting timelines of AR epidemics and by conducting the first analyses on the virulence potential of these strains.
    More information
    Funded Activity

    Targeting Glycointeractions To Generate New Opportunities To Treat And Prevent Bacterial Infections.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $774,540.00
    Summary
    Bacteria and bacterial toxins can interact with complex sugar structures on human cells called glycans. My research team has identified new and important glycan interactions used by bacteria that cause diseases ranging from pneumonia, meningitis and food borne infections to urinary tract and sexually transmitted diseases. Now that these interactions have been discovered, they can be exploited to create drugs and vaccines that may treat and prevent disease by blocking the glycan interactions.
    More information
    Funded Activity

    Structural And Functional Analysis Of Glucosyltransferases (Gtr) Involved In O-antigen Modification Of Shigella Flexneri

    Funder
    National Health and Medical Research Council
    Funding Amount
    $340,976.00
    Summary
    Shigellosis caused by Shigella flexneri is a medically significant disease in developing countries. Serotypes of S. flexneri are determined by bacterial cell-surface polysaccharides called O-antigens. Bacterial viruses carry the genes which confer O-antigen modification giving rise to different serotypes. The project will address fundamental processes related to the O-antigen modification by studying structure and function of the enzymes encoded by the O-antigen modification gene cluster.
    More information
    Funded Activity

    Molecular Basis Of O-antigen Modification And Genomics Of Serotype-converting Bacteriophages Of Shigella Flexneri

    Funder
    National Health and Medical Research Council
    Funding Amount
    $268,264.00
    Summary
    There are approximately 165 million cases of shigellosis world wide annually, resulting in 1.1 million deaths. The majority of cases occur in developing countries and most deaths occur in children under 5 years of age. Shigellosis is mainly caused by the bacterium Shigella flexneri. There are 13 different serotypes of S. flexneri determined by bacterial cell-surface polysaccharides called O-antigens. Bacterial viruses (bacteriophages) carry the genes which confer O-antigen variation. Infection a .... There are approximately 165 million cases of shigellosis world wide annually, resulting in 1.1 million deaths. The majority of cases occur in developing countries and most deaths occur in children under 5 years of age. Shigellosis is mainly caused by the bacterium Shigella flexneri. There are 13 different serotypes of S. flexneri determined by bacterial cell-surface polysaccharides called O-antigens. Bacterial viruses (bacteriophages) carry the genes which confer O-antigen variation. Infection and subsequent incorporation of the virus into the genetic material of the bacterial cell result in modification of the bacterial O-antigen. This phage-mediated O-antigen modification gives rise to different serotypes. The project will address fundamental processes related to the O-antigen modification. This will be achieved by studying structure and function of the enzymes encoded by the O-antigen modification gene cluster. We have isolated several serotype-converting bacteriophages from S. flexneri and we plan to compare and characterise their genomic information to increase understanding of their origin and relationship with the bacterial host.
    Read more Read less
    More information
    Funded Activity

    Novel Therapeutic And Preventive Strategies For Clostridium Difficile Infections.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $508,556.00
    Summary
    The bacterium Clostridium difficile is the major cause of nosocomial diarrhoea in many countries, including Australia. More virulent isolates have recently emerged, leading to increased incidence and disease severity in many countries. This project will make a major contribution to our understanding of how these bacteria cause disease. Preventive or treatment measures based on these research findings will help to prevent or lessen the severity of any epidemics that occur in Australia.
    More information
    Funded Activity

    A New Mechanism For Transposition Of Antibiotic Resistance Genes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $501,839.00
    Summary
    Understanding how antibiotic resistance genes are acquired by bacteria is important if we are to understand how bacteria become resistant in so many antibiotics, limiting treatment options. This project will investigate the way a family of insertion sequences captures and then moves resistance genes. This mechanism contributes to resistance in many bacterial pathogens including ones that are resistant to many different antibiotics.
    More information
    Funded Activity

    How Insertion Sequences Mobilize Antibiotic Resistance Genes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $675,086.00
    Summary
    Resistance to all antibiotics available for treatment of bacterial infections is a cause for global concern (Word Health Organization, US Centres for Disease Control) as it also compromises therapies relying on antibiotics such as transplantation and cancer chemotherapy. This project will seek to understand how resistance genes are recruited and disseminated into different types of bacteria that repeatedly spread around the world.
    More information

    Showing 1-10 of 118 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback